MRNA

Marina Biotech, Inc.

 
Common Stock
OTC Pink Limited Information

OTC Disclosure & News Service

Release Date Title Type
Dec 06, 2012 Marina Biotech, Inc. Announces Year-to-Date 2012 Financial Results and Highlights Corporate Accomplishments Press Release
Dec 05, 2012 Marina Biotech Announces that Licensee ProNAi Therapeutics Reported Phase 1 Study Results using SMARTICLES® Nucleic Acid Delivery Technology Press Release
Dec 04, 2012 Marina Biotech Receives Key Patent Issuance from the USPTO for its Unlocked Nucleobase Analog (UNA) Chemistry - Patent broadly covers RNA-based oligonucleotide therapeutics containing a UNA Press Release
Nov 29, 2012 Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement Press Release
Oct 11, 2012 Marina Biotech, Inc. Announces Full Year 2011 Financial Results Press Release
Aug 22, 2012 Marina Biotech Provides Update on Company Operations Press Release
Aug 03, 2012 Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement for Nucleic Acid Chemistry Press Release
Jun 01, 2012 Marina Biotech Ceases Most Day-to-Day Operations Press Release
May 21, 2012 Marina Biotech and Girindus Group Announce Strategic Alliance Press Release
May 10, 2012 Marina Biotech Receives Three Notices of Allowances from the USPTO and an Intent to Grant Notice from the European Patent Office Press Release
May 08, 2012 Marina Biotech Announces Worldwide Exclusive Licensing Agreement with Monsanto Press Release
Apr 19, 2012 Marina Biotech Regains Intellectual Property Rights to its tkRNAi™ Technology for Agriculture and Veterinary Uses Press Release
Apr 03, 2012 Marina Biotech Completes Dosing of Second Cohort in the Phase 1b START-FAP Clinical Trial of CEQ508 Press Release
Mar 19, 2012 Marina Biotech, Inc. to Raise $1.2 Million in Registered Direct Offering Press Release
Mar 14, 2012 Marina Biotech and ProNAi Therapeutics Announce License Agreement for the Development of DNAi-based Therapeutics Press Release
Feb 29, 2012 Marina Biotech Presents Advances in Oral Delivery of Nucleic Acids at AsiaTIDES Conference in Tokyo Press Release
Feb 22, 2012 Marina Biotech Receives Notice of Allowance for U.S. Patent Related to Its Lipid Based Nucleic Acid Drug Delivery Platform Press Release
Feb 14, 2012 Marina Biotech Announces Closure of Cambridge Site and Consolidation of R&D Operations in Bothell, WA Press Release
Feb 10, 2012 Marina Biotech Announces Closing of $1.5 MM Bridge Loan Press Release
Feb 01, 2012 Marina Biotech Begins Trading on the OTCQX Tier of OTC Market Press Release